ArticleJournal of family medicine and primary care2025
Diabetic retinopathy screening using artificial intelligence and its predictors among people with type 2 diabetes mellitus in an urban area of Durgapur.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycaemia either due to insulin resistance or due to relative or absolute insulin deficiency. Poorly controlled DM may result in both macrovascular and/or microvascular complications like diabetic retinopathy [DR]. Dilated eye examination is the most commonly employed method to diagnose DR. Nonmydriatic artificial intelligence [AI]-based technologies are the now available to screen DR. Methods: A cross-sectional observational study was conducted in urban field practice area of our medical college for 2 months duration. A total of 95 patients with type 2 DM were interviewed using predesigned, pretested semistructured schedule to collect data. Medical records were reviewed to collect relevant information. DR was screened using AI-based DR screening instrument, and venous blood sample was collected for glycated hemoglobin (HbA1C) testing. Data were analyzed using IBM SPSS [version 16]. Univariate and multivariate logistic regression tests were used, and Results: The prevalence of DR was 17.9% in our study. Around 76.9% respondents had high fasting blood glucose [FBG: ≥126 mg/dl], and majority of the respondents [73.7%] had HbA1C value >7%. DR was significantly associated with FBG level, longer duration of diabetes, presence of hypertension, dyslipidemia, and kidney disease in univariate logistic regression and, in multivariable logistic regression, FBG level, presence of dyslipidemia and kidney disease retained their significance. Conclusion: This study had used AI-based DR screening instrument, to screen DR among T2DM patients. AI-based DR screening system can be encouraged in mass screening camps, especially in areas with inadequate number of ophthalmologists. This study also evaluated some important modifiable predictors of DR. Appropriate and early identification of such predictors may prevent DR-related blindness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.